ProThera Biologics (United States)
- Research works
- 37 ▼ 30% vs 2018-21
- Citations
- 1.1k 30.8 per fractional work
- Top-10% rate
- 7.6% all institutions 10.0%
- Open access
- 33% world 40%
- International
- 18% world 18%
Not ranked overall: ProThera Biologics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does ProThera Biologics (United States) work in?
In all years, 48% of research at ProThera Biologics (United States) is in Life Sciences, 47% in Health Sciences. Its largest fields are Medicine (43%), Biochemistry, Genetics and Molecular Biology (23%), Immunology and Microbiology (13%). It does 2.4× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 15 fields, with their numbers
- Life Sciences1848.2%
- Health Sciences1746.9%
- Medicine1642.6%
- Nursing12.3%
- Veterinary01.1%
- Dentistry00.5%
- Health Professions00.3%
- Physical Sciences24.8%
- Environmental Science12.0%
- Chemistry01.1%
- Engineering00.8%
- Materials Science00.8%
- Social Sciences00.1%
- Psychology00.1%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at ProThera Biologics (United States)?
Ranked on the quality score, Yow‐Pin Lim lead among researchers whose main affiliation is ProThera Biologics (United States).
- 1
Yow‐Pin Lim
United States · #6,259,762 worldwide 2.3k citations · 95 works
Which keywords describe research at ProThera Biologics (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cancer, Preterm Infants, Neurodevelopmental Outcomes, Immunotherapy, Gene Therapy, Tumor Targeting and Epidemiology.
- Enzymes
- Macrophage
- Extracellular Matrix
- Activation
- Neurodegeneration
- Autoimmunity
- PET Imaging
- Management
- Toll-like Receptors
- Therapeutic Antibodies
- Innate Immunity
- Immunity
- Biomarkers
- Neonatal Encephalopathy
- Glycosylation
- Arginine Deprivation
- Tumor Targeting
- Neurodevelopmental Outcomes
- Preterm Infants
- Epidemiology
- Inflammation
- Cancer
- Immunotherapy
- Gene Therapy
- Antifungal Therapy
- Bacterial Therapy
- Hypoxic-Ischemic Encephalopathy
- Angiogenesis
- Candidiasis
- Invasive Fungal Infections
- Monoclonal Antibodies
- Metabolism
- Innate Antiviral Responses
- Pattern Recognition Receptors
- Antibody Engineering
- Fc Receptors
- Tumor Microenvironment
- Critical Care
- Infection
- Neuroinflammation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation9▲ 10.0×19 topics
- Epidemiology4▲ 2.7×11 topics
- Cancer4▲ 7.0×11 topics
- Preterm Infants3▲ 55×3 topics
- Immunotherapy3▲ 11×4 topics
- Neurodevelopmental Outcomes3▲ 37×4 topics
- Gene Therapy2▲ 26×2 topics
- Tumor Targeting2▲ 52×2 topics
- Antifungal Therapy2▲ 63×3 topics
- Arginine Deprivation2▲ 145×1 topic
- Bacterial Therapy2▲ 145×1 topic
- Glycosylation2▲ 25×2 topics
- Hypoxic-Ischemic Encephalopathy2▲ 148×1 topic
- Neonatal Encephalopathy2▲ 148×1 topic
- Angiogenesis2▲ 13×6 topics
- Biomarkers2▲ 8.5×6 topics
- Candidiasis2▲ 104×1 topic
- Immunity2▲ 14×3 topics
- Invasive Fungal Infections2▲ 130×1 topic
- Innate Immunity2▲ 13×4 topics
- Monoclonal Antibodies2▲ 33×2 topics
- Therapeutic Antibodies2▲ 36×2 topics
- Metabolism2▲ 6.6×3 topics
- Toll-like Receptors2▲ 26×3 topics
- Innate Antiviral Responses1▲ 57×1 topic
- Management1▲ 4.9×3 topics
- Pattern Recognition Receptors1▲ 27×1 topic
- PET Imaging1▲ 16×3 topics
- Antibody Engineering1▲ 33×1 topic
- Autoimmunity1▲ 16×3 topics
- Fc Receptors1▲ 33×1 topic
- Neurodegeneration1▲ 10×2 topics
- Tumor Microenvironment1▲ 9.4×4 topics
- Activation1▲ 89×1 topic
- Critical Care1▲ 14×3 topics
- Extracellular Matrix1▲ 13×4 topics
- Infection1▲ 10×2 topics
- Macrophage1▲ 55×1 topic
- Neuroinflammation1▲ 11×3 topics
- Enzymes1▲ 71×2 topics
Which research topics does ProThera Biologics (United States) publish most on?
By volume in 2022-now: Neonatal and fetal brain pathology, Ecology and Vegetation Dynamics Studies, Plant and animal studies and Neuroscience of respiration and sleep.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Neonatal and fetal brain pathology Pediatrics, Perinatology and Child Health 0 works
- 2 Ecology and Vegetation Dynamics Studies Nature and Landscape Conservation 0 works
- 3 Plant and animal studies Ecology, Evolution, Behavior and Systematics 0 works
- 4 Neuroscience of respiration and sleep Endocrine and Autonomic Systems 0 works
- 5 Biochemical and Structural Characterization Molecular Biology 0 works
- 6 Neonatal Respiratory Health Research Pulmonary and Respiratory Medicine 0 works
- 7 Plant Taxonomy and Phylogenetics Ecology, Evolution, Behavior and Systematics 0 works
- 8 Geography and Environmental Studies Water Science and Technology 0 works
- 9 Botany, Ecology, and Taxonomy Studies Plant Science 0 works
- 10 S100 Proteins and Annexins Molecular Biology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has ProThera Biologics (United States)'s research output changed?
Output in 2022-2025 was 30% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is ProThera Biologics (United States) as a percentage of every work published that year, 0.000016% in 2024.
Fractional works of ProThera Biologics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in East Providence
- CNS Research (United States)
- Response Technologies (United States)
- Evans Capacitor (United States)
- American Academy of Addiction Psychiatry
- Rhode Island Mood and Memory Research Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about ProThera Biologics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.